Peter Zandstra

Peter Zandstra, Scientific Founder and Chief Technology Officer

Dr. Zandstra is Scientific Co-Founder and the Chief Technology Officer of ExCellThera. In addition, he is the Chief Scientific Officer for the Centre for Commercialization of Regenerative Medicine (CCRM), and he holds an academic appointment as a Professor at the University of Toronto’s Institute of Biomaterials and Biomedical Engineering.

Dr. Zandstra’s research focuses on understanding how complex communication networks between stem cells and their progeny influence self-renewal and differentiation, and how this information can be applied to the design of novel culture technologies capable of controlling cell fate.

Dr. Zandstra is the Canada Research Chair in Stem Cell Bioengineering and a recipient of a number of awards and fellowships, including the Premiers Research Excellence Award (2002), the E.W.R. Steacie Memorial Fellowship (2006), the John Simon Guggenheim Memorial Foundation Fellowship (2007), and the University of Toronto’s McLean Award (2009). Dr. Zandstra is a Fellow of the American Institute for Medical and Biological Engineering, the American Association for the Advancement of Science, and the Royal Society of Canada. Dr. Zandstra was named to Canada’s Top 40 Under 40 (2008) and is a recipient of the Till and McCulloch Award (2013).

Peter Zandstra graduated with a Bachelor of Engineering degree from McGill University in the Department of Chemical Engineering, obtained his Ph.D. degree from the University of British Columbia in the Department of Chemical Engineering and Biotechnology and continued his research training as a Postdoctoral Fellow in the field of Bioengineering at the Massachusetts Institute of Technology.